Page last updated: 2024-08-16

temozolomide and ergoline

temozolomide has been researched along with ergoline in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buchfelder, M1
Matsuno, A1
Bilbao, I; Egaña, N; García, C; Olaizola, I1

Reviews

2 review(s) available for temozolomide and ergoline

ArticleYear
Management of aggressive pituitary adenomas: current treatment strategies.
    Pituitary, 2009, Volume: 12, Issue:3

    Topics: Cabergoline; Dacarbazine; Dopamine Agonists; Ergolines; Female; Humans; Male; Pituitary Neoplasms; Somatostatin; Temozolomide

2009
[Recent trends in the pathophysiology and treatment of pituitary adenomas].
    Brain and nerve = Shinkei kenkyu no shinpo, 2009, Volume: 61, Issue:8

    Topics: Adenoma; Antineoplastic Agents; Cabergoline; Corticotropin-Releasing Hormone; Dacarbazine; Ergolines; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypothalamic Hormones; Incidental Findings; Neurosurgical Procedures; Octreotide; Pituitary Neoplasms; Prolactinoma; Receptors, Neuropeptide; Receptors, Pituitary Hormone-Regulating Hormone; Temozolomide

2009

Other Studies

1 other study(ies) available for temozolomide and ergoline

ArticleYear
Failure of a second temozolomide cycle in a patient with a prolactin-secreting pituitary carcinoma.
    Endocrinologia, diabetes y nutricion, 2017, Volume: 64, Issue:10

    Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bromocriptine; Cabergoline; Combined Modality Therapy; Dacarbazine; Drug Substitution; Ergolines; Fatal Outcome; Headache; Humans; Hyperprolactinemia; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Prolactinoma; Proton Therapy; Temozolomide

2017